These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6452795)

  • 1. Safety data on zimelidine hydrochloride following an overdose.
    Georgotas A; Mann J; Bush D; Gershon S
    Acta Psychiatr Scand Suppl; 1981; 290():257-61. PubMed ID: 6452795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zimelidine: a review of its pharmacological properties and therapeutic efficacy in depressive illness.
    Heel RC; Morley PA; Brogden RN; Carmine AA; Speight TM; Avery GS
    Drugs; 1982 Sep; 24(3):169-206. PubMed ID: 6215240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pharmacokinetics of zimelidine and desipramine in man following acute and chronic administration.
    Potter WZ; Calil HM; Extein I; Zavadil AP; Goodwin FK
    Psychiatry Res; 1979 Dec; 1(3):273-81. PubMed ID: 298355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular and anticholinergic effects of zimelidine.
    Lindbom LO; Malatray J; Hall H; Ogren SO
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):403-6. PubMed ID: 6219432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of zimelidine and desipramine on serotonin and noradrenaline uptake mechanisms in relation to plasma concentrations and to therapeutic effects during treatment of depression.
    Aberg-Wistedt A; Jostell KG; Ross SB; Westerlund D
    Psychopharmacology (Berl); 1981; 74(4):297-305. PubMed ID: 6457309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction studies between three antidepressant drugs (chlorimipramine, imipramine and zimelidine) and noradrenaline, tyramine and vagal stimulation on the heart rate and blood pressure in dogs.
    Johnsson G; Lundborg P; Welin-Fogelberg I
    Acta Pharmacol Toxicol (Copenh); 1979 Sep; 45(3):192-7. PubMed ID: 506741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical effects of zimelidine in man.
    Bertilsson L; Tuck JR; Siwers B
    Eur J Clin Pharmacol; 1980 Nov; 18(6):483-7. PubMed ID: 6450684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled cross-over study of a 5-HT uptake inhibiting and an NA uptake inhibiting antidepressant.
    Aberg A
    Acta Psychiatr Scand Suppl; 1981; 290():244-55. PubMed ID: 6452794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinical trial of zimelidine in depression.
    Georgotas A; Mann J; Bush D; Gershon S
    Commun Psychopharmacol; 1980; 4(1):71-7. PubMed ID: 6447007
    [No Abstract]   [Full Text] [Related]  

  • 10. A double blind comparison of zimelidine and amitriptyline in endogenous depression.
    Montgomery SA; McAuley R; Rani SJ; Roy D; Montgomery DB
    Acta Psychiatr Scand Suppl; 1981; 290():314-27. PubMed ID: 6452798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression. II. Biochemical findings.
    Aberg-Wistedt A; Ross SB; Jostell KG; Sjöquist B
    Acta Psychiatr Scand; 1982 Jul; 66(1):66-82. PubMed ID: 6181652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in saliva secretion and accommodation width during short-term administration of imipramine and zimelidine in healthy volunteers.
    von Knorring L
    Int Pharmacopsychiatry; 1981; 16(2):69-78. PubMed ID: 6460717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression. I. Clinical findings.
    Aberg-Wistedt A
    Acta Psychiatr Scand; 1982 Jul; 66(1):50-65. PubMed ID: 6214925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zimelidine - a serotonin uptake blocker in the treatment of phobic anxiety.
    Evans L; Best J; Moore G; Cox J
    Prog Neuropsychopharmacol; 1980; 4(1):75-9. PubMed ID: 6447309
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiovascular effects of zimelidine and other antidepressant in conscious rats.
    Lindbom LO; Forsberg T
    Acta Psychiatr Scand Suppl; 1981; 290():380-4. PubMed ID: 6452801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zimelidine to geriatric patients: a pharmacokinetic and clinical study.
    Dehlin O; Björnsson G; Lundström J
    Acta Psychiatr Scand Suppl; 1981; 290():410-24. PubMed ID: 6452803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zimelidine in chronic suicidal behaviour.
    O'Connor M; Pettiford J
    Aust N Z J Psychiatry; 1982 Dec; 16(4):296-7. PubMed ID: 6220693
    [No Abstract]   [Full Text] [Related]  

  • 18. A double-blind evaluation of zimelidine in comparison to placebo and amitriptyline in patients with major depressive disorder.
    Claghorn J; Gershon S; Goldstein BJ; Behrnetz S; Bush DF; Huitfeldt B
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(2-3):367-82. PubMed ID: 6225150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled trial of zimelidine, a 5-HT reuptake inhibitor, for treatment of depression.
    Georgotas A; Krakowski M; Gershon S
    Am J Psychiatry; 1982 Aug; 139(8):1057-8. PubMed ID: 6211994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of zimelidine. Systemic availability of zimelidine and norzimelidine in human volunteers.
    Brown D; Scott DH; Scott DB; Meyer M; Westerlund D; Lundström J
    Eur J Clin Pharmacol; 1980 Feb; 17(2):111-6. PubMed ID: 6445274
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.